Nathan Vastesaeger

Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, Part 1

Joachim Sieper, Jan Lenaerts, J. Wollenhaupt et al. · Annals of the Rheumatic Diseases · 2013 · 213 citations · Full text

Medicine, Pharmacotherapy, Pain Management +16

Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery

Bert Vander Cruyssen, Elisa Muñoz-Gomáriz, Pilar Font et al. · Lara D. Veeken · 2009 · 210 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +14

Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study

Asta Baranauskaitė, Helena Raffayová, Algirdas Venalis et al. · Annals of the Rheumatic Diseases · 2011 · 201 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

Predicting the outcome of ankylosing spondylitis therapy

Nathan Vastesaeger, Désirée van der Heijde, Robert D. Inman et al. · Annals of the Rheumatic Diseases · 2011 · 190 citations · Full text

Medicine, Pharmacotherapy, Clinical Epidemiology +15

The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice

Bert Vander Cruyssen, C. Ribbens, A. Boonen et al. · Annals of the Rheumatic Diseases · 2007 · 128 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +14